Causes and Treatment of Tension Headache: A Review

Alnaim, Mounther Mohammed A. and Bukhamsin, Sarah Abdulla A. and AlBurayh, Yasamiyan Ali and Alshadly, Mahmoud Refat S. and Almaslamani, Khalid Waleed M. and Alatawi, Wejdan Lafi S. and Saber, Mohannad Abduljaleel A. and Alzahrani, Shahad Abdulaziz S. and Alzuwayyid, Ali Hussain I. and Alomrani, Heba Homoud H. and Alamrani, Amal hamoud and Al Masoud, Dalal Khalid H. and Alruwaili, Alaa Nemer S. and Alghamdi, Kholoud Mohammed O. and Alkhediwi, Lama Mohammed A. (2021) Causes and Treatment of Tension Headache: A Review. Journal of Pharmaceutical Research International, 33 (56A). pp. 288-293. ISSN 2456-9119

[thumbnail of 4668-Article Text-6755-1-10-20221006.pdf] Text
4668-Article Text-6755-1-10-20221006.pdf - Published Version

Download (326kB)

Abstract

Tension-type headache (TTH) is the most prevalent primary headache problem, affecting 46 percent to 78 percent of people at some point in their lives. However, the majority have episodic infrequent TTH (1 day per month or fewer) with no specific need for medical treatment. The diagnosis is made based on the patient's medical history and physical examination. The exact etiology of tension-type headache is unknown. The most likely cause of rare tension-type headaches is activation of hyperexcitable peripheral afferent neurons from head and neck muscles. Nondrug management is commonly utilized and should be considered for all patients with TTH. The scientific evidence for the efficacy of most treatment approaches, on the other hand, is limited. Pharmacological treatment depends on whether the headache is acute or chronic. In this review we will cover the disease epidemiology, etiology, diagnosis, and management.

The aim is to study the Causes and Treatment of Tension Headache method a population-based study in Denmark, About 24% to 37% of the population experienced TTH several times a month, 10% had it weekly, and 2% to 3% of the population had chronic TTH,

In contrast to migraine, women are only slightly more affected than males (the female-to-male ratio of TTH is 5:4), and onset is delayed (25 to 30 years). Between the ages of 30 and 39.

Item Type: Article
Subjects: Open STM Article > Medical Science
Depositing User: Unnamed user with email support@openstmarticle.com
Date Deposited: 03 Apr 2023 07:32
Last Modified: 29 Apr 2024 07:46
URI: http://asian.openbookpublished.com/id/eprint/119

Actions (login required)

View Item
View Item